XBP1 and plasma cell myeloma: 17-AAG treatment to myeloma cells induced splicing of XBP1, upregulation of CHOP, and activation of ATF6, and induced cell death with activation of JNK and caspase cleavage, indicating that HSP90 inhibitors induce myeloma cell death in part via ER stress and UPR pathway.59